Technical University of Munich, School of Medicine, Department of Psychiatry and Psychotherapy, Munich, Germany.
Technical University of Munich, School of Medicine, Münchner Studienzentrum, Munich, Germany.
J Alzheimers Dis. 2021;81(2):843-852. doi: 10.3233/JAD-210046.
End of life symptoms and symptom management as well as the quality of dying (QoD) of persons with advanced dementia (PWAD) have not yet been systematically studied in Germany.
The study was performed in the context of the project EPYLOGE (IssuEs in Palliative care for persons in advanced and terminal stages of Young-onset and Late-Onset dementia in Germany). Closest relatives of recently deceased patients with advanced YOD (N = 46) and LOD (N = 54) living at home or in long term care were interviewed.
Circumstances of death, symptoms, and treatment appeared to be similar between YOD and LOD, except that persons with LOD had significantly more somatic comorbidities and were admitted to hospital in the last three months of life more often than persons with LOD. At end of life, 60% of PWAD appeared to be "at peace". Difficulty swallowing, gurgling, shortness of breath, and discomfort were observed most frequently. Large interindividual differences in suffering and QoD were present. Determinants of QoD were not identified.
Our findings suggest that low QoD was caused by inadequate recognition and/or insufficient treatment of burdensome physical and emotional symptoms. PWADs' needs should be assessed regularly, and strategies focusing on treatment and implementing support for both the patient and caregiver must be established.
在德国,关于终末期症状和症状管理以及晚期痴呆症(PWAD)患者的临终质量(QoD)尚未进行系统研究。
1)调查最近去世的 PWAD 的终末期症状、治疗和护理、预先护理计划以及死亡情况;2)确定年轻起病和晚起病痴呆(YOD 和 LOD)之间是否存在差异。
该研究是在 EPYLOGE 项目的背景下进行的(德国年轻和晚期起病痴呆晚期患者的姑息治疗问题)。对最近在家中或长期护理中去世的晚期 YOD(N = 46)和 LOD(N = 54)患者的近亲进行了访谈。
YOD 和 LOD 之间的死亡情况、症状和治疗似乎相似,除了 LOD 患者的躯体合并症明显更多,并且在生命的最后三个月中更经常住院治疗。在生命的尽头,60%的 PWAD 似乎“平静”。吞咽困难、汩汩声、呼吸急促和不适是最常见的症状。患者的痛苦和 QoD 存在很大的个体差异。未确定 QoD 的决定因素。
我们的研究结果表明,低 QoD 是由于对身体和情绪负担症状的识别不足和/或治疗不足引起的。应定期评估 PWAD 的需求,并制定专注于治疗和为患者和护理人员提供支持的策略。